Table 2. Perioperative data.
Ropivacaine group | Placebo group | |
Number of patients | 14 | 16 |
Operated side (right/left) | 8/6 | 6/10 |
Duration of surgery (min) | 146 (82–194) | 138 (100–164) |
Order of revision performed: | ||
1. Revision | 6/14 (43) | 8/16 (50) |
2. Revision | 5/14 (36) | 6/16 (38) |
3. Revision | 3/14 (21) | 1/16 (6) |
4. Revision | 0/14 (0) | 1/16 (6) |
Reason for revision TKA * : | ||
Septic loosening | 2/14 (14) | 4/14 (25) |
Aseptic loosening | 6/14 (43) | 5/14 (31) |
Component malposition | 3/14 (21.5) | 2/14 (12.5) |
Instability | 3/14 (21.5) | 3/14 (19) |
Stiffness | 0/14 (0) | 2/14 (12.5) |
Blood loss (ml) | 150 (0–450) | 200 (0–480) |
Isotonic sodium chloride (ml) | 1250 (650–2625) | 1250 (520–2010) |
Hydroxyethyl starch colloids (ml) | 0 (0–350) | 0 (0–500) |
Values are reported as number of subjects, proportions (percentage) or median (10–90%).
*TKA = total knee arthroplasty.